Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Nicholas Ingraham and Christopher Tignanelli.
Connection Strength

5.309
  1. Racial and Ethnic Disparities in Hospital Admissions from COVID-19: Determining the Impact of Neighborhood Deprivation and Primary Language. J Gen Intern Med. 2021 11; 36(11):3462-3470.
    View in: PubMed
    Score: 0.946
  2. Immunomodulation in COVID-19. Lancet Respir Med. 2020 06; 8(6):544-546.
    View in: PubMed
    Score: 0.880
  3. Fact Versus Science Fiction: Fighting Coronavirus Disease 2019 Requires the Wisdom to Know the Difference. Crit Care Explor. 2020 Apr; 2(4):e0108.
    View in: PubMed
    Score: 0.879
  4. Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2. Crit Care. 2020 04 28; 24(1):182.
    View in: PubMed
    Score: 0.879
  5. A multi-center phase II randomized clinical trial of losartan on symptomatic outpatients with COVID-19. EClinicalMedicine. 2021 Jul; 37:100957.
    View in: PubMed
    Score: 0.238
  6. Characterizing COVID-19 clinical phenotypes and associated comorbidities and complication profiles. PLoS One. 2021; 16(3):e0248956.
    View in: PubMed
    Score: 0.234
  7. Outpatient metformin use is associated with reduced severity of COVID-19 disease in adults with overweight or obesity. J Med Virol. 2021 07; 93(7):4273-4279.
    View in: PubMed
    Score: 0.234
  8. mTOR inhibition in COVID-19: A commentary and review of efficacy in RNA viruses. J Med Virol. 2021 04; 93(4):1843-1846.
    View in: PubMed
    Score: 0.230
  9. Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis. Lancet Healthy Longev. 2021 Jan; 2(1):e34-e41.
    View in: PubMed
    Score: 0.229
  10. Understanding the renin-angiotensin-aldosterone-SARS-CoV axis: a comprehensive review. Eur Respir J. 2020 07; 56(1).
    View in: PubMed
    Score: 0.223
  11. Antihypertensive drugs and risk of COVID-19? Lancet Respir Med. 2020 05; 8(5):e30-e31.
    View in: PubMed
    Score: 0.218
  12. A fast, resource efficient, and reliable rule-based system for COVID-19 symptom identification. JAMIA Open. 2021 Jul; 4(3):ooab070.
    View in: PubMed
    Score: 0.060
  13. We Should Do More to Offer Evidence-Based Treatment for an Important Modifiable Risk Factor for COVID-19: Obesity. J Prim Care Community Health. 2021 Jan-Dec; 12:2150132721996283.
    View in: PubMed
    Score: 0.058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.